ICMR Licenses Nine Breakthrough Health Technologies at MedTech Expo
In a major boost to indigenous medical technology, the Indian Council of Medical Research (ICMR) licensed nine cutting-edge health technologies to various industry partners at the India MedTech Expo 2025 on September 4, 2025. This initiative, under the 'Medical Innovations ā Patent Mitra' program, aims to accelerate the transfer of publicly funded innovations to industry for large-scale implementation and affordable public access. The licensed technologies include diagnostics for infectious diseases such as Nipah, Monkeypox, Chikungunya, Japanese Encephalitis, and Dengue viruses. Furthermore, a multistage malaria vaccine and novel Shigella and Salmonella vaccines were also part of the licensing deals. This move signifies a collaborative effort between public research and private enterprise to deliver high-quality, homegrown medical innovations across the nation.
PM Modi Emphasizes Startup Role in India's Semiconductor Future
Prime Minister Narendra Modi highlighted the critical role of startups and Intellectual Property (IP) creation in advancing India's semiconductor industry during Semicon India 2025 on September 4, 2025. The Prime Minister underscored the government's commitment to fostering a robust semiconductor ecosystem. During the event, PM Modi also received the first set of "Made-in-India" chips from a pilot production line, hailing it as a historic milestone for the country's semiconductor journey. This reiterates India's push for self-reliance in cutting-edge technology manufacturing.
IIT-Bombay Develops Advanced Traffic Control Framework
Researchers from the Indian Institute of Technology (IIT)-Bombay, in collaboration with Australia's Monash University, have developed a computationally efficient mathematical framework to evaluate decentralized traffic control policies. Published on September 5, 2025, this breakthrough aims to accelerate the design of next-generation intelligent traffic systems, offering a faster and more cost-effective way to test algorithms and identify effective strategies for urban mobility. This research is particularly significant for Indian cities grappling with increasing congestion, promising to aid traffic engineers and urban planners in designing smarter and more resilient systems.
Indian Scientists Uncover Protein p47's Role in Cellular Protection
A groundbreaking study by Indian scientists, reported on September 4, 2025, has revealed the significant role of a lesser-known protein, p47, as a mechanical chaperone. This discovery sheds light on how p47 protects cells from mechanical stress, potentially opening new avenues for treating diseases where protein stability under physical strain is compromised, such such as heart muscle disorders and laminopathies.
Enzene Biosciences Inaugurates $50M Bio-Pharma Plant in US
Pune-based global biotech company, Enzene Biosciences, Ltd., a subsidiary of Alkem Laboratories, Ltd., officially opened its state-of-the-art $50 million biopharmaceutical manufacturing plant on the Princeton West Innovation Campus in Hopewell, USA, on September 4, 2025. This strategic expansion aims to provide North American biopharmaceutical companies with streamlined supply chains, faster turnaround times, and enhanced communication, contributing to the advancement of global healthcare.
India and Singapore Explore Defence Technology Co-Development
India and Singapore are actively exploring possibilities for co-developing technologies in the defence sector, as announced on September 4, 2025, following discussions between the two nations. This move is part of strengthening their existing defence cooperation and aims to foster joint production and sharing of outputs from such collaborations. The agreement to explore cooperation in the defence technology space was highlighted during Singapore PM Lawrence Wong's official visit to India.